Meeder Asset Management’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-19,551
| Closed | -$70K | – | 2526 |
|
|
2019
Q3 | $70K | Buy |
19,551
+17,035
| +677% | +$61K | ﹤0.01% | 906 |
|
|
2019
Q2 | $7K | Sell |
2,516
-1,069
| -30% | -$2.97K | ﹤0.01% | 1590 |
|
|
2019
Q1 | $11K | Sell |
3,585
-22,891
| -86% | -$70.2K | ﹤0.01% | 1230 |
|
|
2018
Q4 | $42K | Buy |
26,476
+13,706
| +107% | +$21.7K | ﹤0.01% | 861 |
|
|
2018
Q3 | $46K | Buy |
12,770
+11,507
| +911% | +$41.5K | ﹤0.01% | 806 |
|
|
2018
Q2 | $3.57K | Hold |
1,263
| – | – | ﹤0.01% | 1329 |
|
|
2018
Q1 | $5K | Buy |
1,263
+116
| +10% | +$459 | ﹤0.01% | 1258 |
|
|
2017
Q4 | $3K | Buy |
1,147
+213
| +23% | +$557 | ﹤0.01% | 1462 |
|
|
2017
Q3 | $4K | Sell |
934
-994
| -52% | -$4.26K | ﹤0.01% | 1348 |
|
|
2017
Q2 | $9K | Sell |
1,928
-147
| -7% | -$686 | ﹤0.01% | 1035 |
|
|
2017
Q1 | $9K | Hold |
2,075
| – | – | ﹤0.01% | 894 |
|
|
2016
Q4 | $9K | Buy |
+2,075
| New | +$9K | ﹤0.01% | 783 |
|